-
Pharmac's role in the response to COVID-19
Summary of Pharmac's work in the response to COVID-19.
-
New Zealand’s COVID-19 treatments portfolio
-
COVID-19 antivirals: Access Criteria
Access criteria for oral COVID-19 medicines, Paxlovid and Lagevrio.
-
COVID-19 vaccines
Read about the Vaccine Strategy and our role
-
Changes to funding criteria for long-acting muscarinic agonists
Spirometry not needed for COPD diagnosis..
-
COVID-19: Supply chain update
The impact of COVID-19 cases is being felt within the supply chain.
-
Dispensing frequency
Which medicines have dispensing limits
-
Ivermectin
Ivermectin is not recommended to treat or prevent COVID-19.
-
Hydroxychloroquine
We've limited access to proven indications.
-
OIAs about our Covid-19 response
What we were asked and how we answered.
-
Hospital medical devices and Pharmac
An update from the team
